Ton Lisman
About
Ton Lisman is a scholar working on Hepatology, Surgery and Epidemiology.
According to data from OpenAlex, Ton Lisman has authored 325 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Hepatology, 121 papers in Surgery and 101 papers in Epidemiology. Recurrent topics in Ton Lisman's work include Liver Disease and Transplantation (158 papers), Liver Disease Diagnosis and Treatment (93 papers) and Organ Transplantation Techniques and Outcomes (76 papers). Ton Lisman is often cited by papers focused on Liver Disease and Transplantation (158 papers), Liver Disease Diagnosis and Treatment (93 papers) and Organ Transplantation Techniques and Outcomes (76 papers). Ton Lisman collaborates with scholars based in Netherlands, United States and United Kingdom. Ton Lisman's co-authors include Robert J. Porte, Philip G. de Groot, Jelle Adelmeijer, Frank W.G. Leebeek, Joost C.M. Meijers, Frits R. Rosendaal, Patrick G. Northup, Marieke T. de Boer, Stephen H. Caldwell and R. Todd Stravitz and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.
In The Last Decade
Ton Lisman
313 papers receiving 13.0k citations
Hit Papers
Author Peers
Peers are selected by citation overlap in the author's most active subfields. citations · hero ref
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ton Lisman | 6.7k | 4.8k | 4.4k | 2.7k | 1.6k | 325 | 13.2k | |
| Robert J. Porte | 8.7k 1.3× | 9.2k 1.9× | 3.5k 0.8× | 794 0.3× | 1.0k 0.6× | 363 | 13.5k | |
| Frank W.G. Leebeek | 1.7k 0.3× | 2.4k 0.5× | 2.0k 0.5× | 6.1k 2.2× | 656 0.4× | 392 | 12.3k | |
| Maureane Hoffman | 773 0.1× | 1.8k 0.4× | 1.1k 0.3× | 5.9k 2.2× | 2.1k 1.3× | 203 | 11.6k | |
| Roberto de Franchis | 6.8k 1.0× | 6.0k 1.2× | 6.9k 1.6× | 537 0.2× | 211 0.1× | 187 | 12.2k | |
| Moniek P.M. de Maat | 525 0.1× | 1.6k 0.3× | 1.8k 0.4× | 2.2k 0.8× | 308 0.2× | 267 | 8.9k | |
| Byers W. Shaw | 5.3k 0.8× | 6.9k 1.4× | 2.6k 0.6× | 514 0.2× | 406 0.3× | 205 | 10.8k | |
| S. Breanndan Moore | 1.3k 0.2× | 1.7k 0.4× | 1.9k 0.4× | 1.4k 0.5× | 1.4k 0.9× | 132 | 8.1k | |
| Michael Makris | 727 0.1× | 1.5k 0.3× | 882 0.2× | 6.4k 2.3× | 316 0.2× | 242 | 9.8k | |
| Shoshana Revel‐Vilk | 537 0.1× | 958 0.2× | 1.3k 0.3× | 2.1k 0.8× | 249 0.2× | 159 | 5.8k | |
| F E Preston | 969 0.1× | 863 0.2× | 1.2k 0.3× | 4.3k 1.6× | 224 0.1× | 170 | 7.6k |
Countries citing papers authored by Ton Lisman
Since
Specialization
Citations
This map shows the geographic impact of Ton Lisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ton Lisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ton Lisman more than expected).
Fields of papers citing papers by Ton Lisman
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ton Lisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ton Lisman. The network helps show where Ton Lisman may publish in the future.
Co-authorship network of co-authors of Ton Lisman
This figure shows the co-authorship network connecting the top 25 collaborators of Ton Lisman. A scholar is included among the top collaborators of Ton Lisman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ton Lisman. Ton Lisman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Karkouti, Keyvan, Chaya Shwaartz, Marina Englesakis, et al.. (2025). Use of prothrombin complex concentrates in liver transplantation: a systematic review and meta-analysis. British Journal of Anaesthesia. 135(5). 1172–1192.
2.
Fonseca, Marcio A. da, A Newberry, Alexander B. Taylor, et al.. (2025). Integrated cross-linking by TG2 and FXIII generates hepatoprotective fibrin(ogen) deposits in injured liver. Blood. 145(21). 2507–2517.
3.
Zhang, Shuyan, J. Casper Swarte, Johannes R. Björk, et al.. (2025). Gut microbiome dysbiosis is not associated with portal vein thrombosis in patients with end-stage liver disease: a cross-sectional study. Journal of Thrombosis and Haemostasis. 23(4). 1407–1415.
4.
Lascaris, Bianca, Silke B. Bodewes, Jelle Adelmeijer, et al.. (2024). Production of physiological amounts of hemostatic proteins by human donor livers during ex situ long-term normothermic machine perfusion for up to 7 days. Journal of Thrombosis and Haemostasis. 22(11). 3097–3106.
5.
Lisman, Ton, William Bernal, Jelle Adelmeijer, et al.. (2023). Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis. Research and Practice in Thrombosis and Haemostasis. 7(1). 100052–100052.
6.
Beek, André P. van, et al.. (2023). Patients with metabolic dysfunction–associated steatotic liver disease have preserved in vitro responses to antiplatelet drugs. Research and Practice in Thrombosis and Haemostasis. 7(7). 102217–102217.
7.
Groeneveld, Dafna J., Jelle Adelmeijer, Lauren G. Poole, et al.. (2023). Coagulation factor XIII is a critical driver of liver regeneration after partial hepatectomy. Journal of Thrombosis and Haemostasis. 22(3). 620–632.
8.
Swan, Dawn, Ton Lisman, Armando Tripodi, & Jecko Thachil. (2023). The prothrombotic tendency of metabolic-associated fatty liver disease. Journal of Thrombosis and Haemostasis. 21(11). 3045–3055.
9.
Thorne, Adam M., Justina C. Wolters, Bianca Lascaris, et al.. (2023). Bile proteome reveals biliary regeneration during normothermic preservation of human donor livers. Nature Communications. 14(1). 7880–7880.
10.
Scheiner, Bernhard, Lorenz Balcar, Rafael Paternostro, et al.. (2022). Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD. Journal of Hepatology. 76(5). 1090–1099.
11.
Roberts, Lara N., Virginia Hernández–Gea, Maria Magnusson, et al.. (2022). Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 20(10). 2237–2245.
12.
Hu, Yong, Andreas Repa, Ton Lisman, et al.. (2022). Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII. Journal of Thrombosis and Haemostasis. 20(10). 2306–2312.
13.
Nemeth, Banne, Araci M. R. Rondon, Raymond A. van Adrichem, et al.. (2022). Lower-leg injury and knee arthroscopy have distinct effects on coagulation. Blood Advances. 6(17). 5232–5243.
14.
Magaz, Marta, Jelle Adelmeijer, Fanny Turón, et al.. (2022). The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study. Journal of Thrombosis and Haemostasis. 20(9). 2075–2082.
15.
Li, Yanni, Michiel Voskuil, Ranko Gaćeša, et al.. (2021). Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome-wide association study. American Journal of Transplantation. 21(9). 3133–3147.
16.
Meijenfeldt, Fien A. von, R. Todd Stravitz, Jingwen Zhang, et al.. (2021). Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome. Hepatology. 75(3). 623–633.
17.
Rosell, Axel, Sebastian Havervall, Fien A. von Meijenfeldt, et al.. (2020). Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 41(2). 878–882.
18.
Vries, Y. de, Tim Berendsen, Masato Fujiyoshi, et al.. (2019). Transplantation of high-risk donor livers after resuscitation and viability assessment using a combined protocol of oxygenated hypothermic, rewarming and normothermic machine perfusion: study protocol for a prospective, single-arm study (DHOPE-COR-NMP trial). BMJ Open. 9(8). e028596–e028596.
19.
Lisman, Ton, et al.. (2010). The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver. Blood. 117(6). 2070–2072.
20.
Groot, Philip G. de, et al.. (2008). The glycoprotein Ib-IX-V complex contributes to tissue factor–independent thrombin generation by recombinant factor VIIa on the activated platelet surface. Blood. 112(8). 3227–3233.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Robert J. Porte Breakdown of academic impact, for papers by Frank W.G. Leebeek Breakdown of academic impact, for papers by Maureane Hoffman Breakdown of academic impact, for papers by Roberto de Franchis Breakdown of academic impact, for papers by Moniek P.M. de Maat Breakdown of academic impact, for papers by Byers W. Shaw Breakdown of academic impact, for papers by S. Breanndan Moore Breakdown of academic impact, for papers by Michael Makris Breakdown of academic impact, for papers by Shoshana Revel‐Vilk Breakdown of academic impact, for papers by F E Preston